Related Experiment Videos
Type 2 polyglandular autoimmune disease (Schmidt's syndrome)
C Betterle1, M Volpato, A N Greggio
1Institute of Semeiotica Medica, Chair of Clinical Immunology and Allergy, University of Padova, Italy.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|March 1, 1996
Summary
This study presents clinical, genetic, and immunological data from sixty patients with type 2 polyglandular autoimmune disease (PGAD). Findings contribute to understanding this rare autoimmune disorder.
Area of Science:
- Endocrinology
- Immunology
- Genetics
Background:
- Polyglandular autoimmune disease (PGAD) is a rare group of disorders characterized by autoimmune polyendocrinopathy.
- Type 2 PGAD involves autoimmune adrenal insufficiency (Addison's disease) and autoimmune thyroid disease (Hashimoto's thyroiditis), often with other autoimmune conditions.
- Understanding the clinical, genetic, and immunological profiles is crucial for diagnosis and management.
Purpose of the Study:
- To present comprehensive data on the clinical, genetic, and immunological characteristics of patients with type 2 polyglandular autoimmune disease (PGAD).
- To review and discuss the existing literature on type 2 PGAD.
Main Methods:
- Retrospective analysis of clinical data from sixty patients diagnosed with type 2 PGAD.
- Inclusion of genetic and immunological assessments.
- Literature review and synthesis of current knowledge.
Main Results:
- Detailed presentation of clinical manifestations, including endocrine and non-endocrine autoimmune conditions observed in the cohort.
- Summary of genetic findings relevant to type 2 PGAD.
- Characterization of immunological profiles, including autoantibody status.
Conclusions:
- The study provides valuable data on the phenotype of type 2 PGAD.
- Highlights the heterogeneity of the disease and the importance of comprehensive evaluation.
- Emphasizes the need for further research into the genetic and immunological underpinnings of type 2 PGAD.